Live Nasdaq Composite: Micron Lifts Market Boat Alongside Mixed Economic Signals

Investing

Eli Lilly : LLY

All Eli Lilly Articles

652 Articles

Rich Duprey | Apr 17, 2025 at 10:08 AM EDT

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

One man’s trash may be another man’s treasure, but dumpster diving when investing carries risks. You have to wade through…

Vandita Jadeja | Apr 4, 2025 at 11:49 AM EDT

These 5 S&P 500 Stocks Are Growing Revenue The Most Right Now

The stock market has been on edge since the announcement of tariffs, reporting its biggest loss since March 2020. The…

Omor Ibne Ehsan | Apr 3, 2025 at 2:58 PM EDT

3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year

Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These…

Vandita Jadeja | Mar 10, 2025 at 9:59 AM EDT

2 Stocks That Could Split Very Soon

Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies…

Rich Duprey | Feb 24, 2025 at 12:36 PM EST

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO | NVO…

Chris MacDonald | Feb 21, 2025 at 12:47 PM EST

This Growth Stock Surged 63% in 2024. Here’s Why 2025 Could Bring An Even Bigger Gain.

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades,…

Ian Cooper | Feb 21, 2025 at 11:47 AM EST

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is…

Rich Duprey | Feb 19, 2025 at 9:41 AM EST

2 Surprising Stocks That Could Be Hurt By Trump’s European Tariffs

President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on “every country”…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Chris MacDonald | Feb 10, 2025 at 10:14 AM EST

My 3 Top Picks for Stocks That Could Double Over the Next 3 Years

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market.…

Rich Duprey | Jan 31, 2025 at 11:18 AM EST

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

Shares of AbbVie (NYSE:ABBV | ABBV Price Prediction) are surging 7% this morning after the pharmaceutical giant reported solid fourth…

Joey Frenette | Jan 23, 2025 at 12:01 PM EST

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After…

Omor Ibne Ehsan | Jan 22, 2025 at 11:15 AM EST

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Eli Lilly (NYSE: LLY | LLY Price Prediction) doesn’t really need much of an introduction. It has become a household…

Rich Duprey | Jan 21, 2025 at 3:15 PM EST

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) has been described as the best pure-play stock in artificial intelligence. The market…

Rich Duprey | Jan 15, 2025 at 9:06 AM EST

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly…

1 … 7 8 9 10 11 … 44

Eli Lilly : LLY

All Eli Lilly Articles

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

These 5 S&P 500 Stocks Are Growing Revenue The Most Right Now

3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year

2 Stocks That Could Split Very Soon

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

This Growth Stock Surged 63% in 2024. Here’s Why 2025 Could Bring An Even Bigger Gain.

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

2 Surprising Stocks That Could Be Hurt By Trump’s European Tariffs

AbbVie Just Paid Investors: Here’s How Much They Received

My 3 Top Picks for Stocks That Could Double Over the Next 3 Years

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Live Nasdaq Composite: Micron Lifts Market Boat Alongside Mixed Economic Signals

A Private Credit Veteran Warns ‘A Canary in the Coal Mine Is Coming’ as a $1.8 Trillion Market Cracks

Trading Near an All-Time Low of $5: 1 Crucial Balance Sheet Metric That Explains Why Lucid Is a Dangerous Capital-Destruction Trap

If You Bought the S&P 500 the Day Trump Won, Here’s Exactly What $10,000 Is Worth Today

Nvidia's CEO Says the Next Millionaires Will Be Plumbers and Electricians, Not Coders

Can't Afford Retirement In Napa? Try This Town Instead

Nvidia’s CEO Says the Next Millionaires Will Be Plumbers and Electricians, Not Coders

A Private Credit Veteran Warns ‘A Canary in the Coal Mine Is Coming’ as a $1.8 Trillion Market Cracks

Eli Lilly : LLY

All Eli Lilly Articles

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

These 5 S&P 500 Stocks Are Growing Revenue The Most Right Now

3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year

2 Stocks That Could Split Very Soon

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

This Growth Stock Surged 63% in 2024. Here’s Why 2025 Could Bring An Even Bigger Gain.

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

2 Surprising Stocks That Could Be Hurt By Trump’s European Tariffs

AbbVie Just Paid Investors: Here’s How Much They Received

My 3 Top Picks for Stocks That Could Double Over the Next 3 Years

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Live Nasdaq Composite: Micron Lifts Market Boat Alongside Mixed Economic Signals

A Private Credit Veteran Warns ‘A Canary in the Coal Mine Is Coming’ as a $1.8 Trillion Market Cracks

Trading Near an All-Time Low of $5: 1 Crucial Balance Sheet Metric That Explains Why Lucid Is a Dangerous Capital-Destruction Trap

If You Bought the S&P 500 the Day Trump Won, Here’s Exactly What $10,000 Is Worth Today

Featured Reads

Nvidia's CEO Says the Next Millionaires Will Be Plumbers and Electricians, Not Coders

Can't Afford Retirement In Napa? Try This Town Instead